US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 2, 2020 (6 years ago)

Metformin Hydrochloride Extended - Release Tablets, USP, 500 mg, a) 100 (NDC…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

What was recalled

Metformin Hydrochloride Extended - Release Tablets, USP, 500 mg, a) 100 (NDC 62037-571-01) and b) 1,000 (NDC 62037-571-10) count bottles, Rx Only, Manufactured by: Watson Pharma Private Limited, Verna, Salcette Goa, Distributed by: Actavis Pharma, Inc., Parsippany, NJ

Recalling firm
Teva Pharmaceuticals USA
NDC code
62037-571-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1331-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all